Skip to main content
S 882 119th Congress Senate Health

Patients Before Middlemen Act

Introduced: March 6, 2025 Introduced by: Blackburn, Marsha Republican · Tennessee See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 6, 2025
Read twice and referred to the Committee on Finance.
Mar 6, 2025
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Patients Before Middlemen Act

This bill establishes certain standards and reporting requirements for prescription drug plan (PDP) sponsors, pharmacy benefit managers (PBMs), and pharmacies under the Medicare prescription drug benefit and Medicare Advantage.

Specifically, the Centers for Medicare & Medicaid Services (CMS) must develop reasonable and relevant standards for contracts between PDP sponsors and pharmacies. The CMS must seek input from interested stakeholders when developing these standards. PDP sponsors are subject to civil penalties for violating these standards; PBMs must reimburse PDP sponsors for civil penalties that result from their responsibilities.

The bill also requires the CMS to report periodically on essential retail pharmacies (i.e., pharmacies that serve as the only pharmacy within a certain radius) with respect to costs, contracts, and other specified information, particularly in relation to other types of pharmacies.

Additionally, PBMs may not receive any income other than flat, bona fide service fees. PBMs must turn over any excess amounts they receive to PDP sponsors; PDP sponsors must turn over these amounts to the CMS. In addition, PBMs must report to PDP sponsors and to the CMS an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with these requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

The bill's changes generally apply beginning in 2028.

What's happening now March 6, 2025

Read twice and referred to the Committee on Finance.

 Related & companion bills 3
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 69

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

See all 69 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). S. 882: Patients Before Middlemen Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-882/
MLA
"S. 882: Patients Before Middlemen Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-882/.
Bluebook (legal)
S. 882, 119th Cong. (2026), https://openamerica.io/bill/119-S-882/.
Markdown link
[S. 882: Patients Before Middlemen Act](https://openamerica.io/bill/119-S-882/)
Report a problem